Litigation

Par Pharmaceutical, Inc. v. Jazz Pharmaceuticals, Inc.

final written decision; all claims unpatentable

IPR2015-00548

Filed
2015-01-08
Terminated
2016-07-27

Patents at issue (1)

Summary

Inter partes review filed by Par Pharmaceutical, Inc. (et al.) against Jazz Pharmaceuticals. The Board instituted review and issued a final written decision on July 27, 2016 holding all claims of U.S. 7,895,059 unpatentable.

Case overview & background

Plain-language overview of the case: parties, accused product, patents at issue, and why the suit matters.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Key legal developments & outcome

Major rulings, motions, claim construction, settlements, and the present posture or final disposition.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

In the news

What the press has reported about this case, summarized with links to the source articles.

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Plaintiff representatives

Counsel of record for the plaintiff(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).

Defendant representatives

Counsel of record for the defendant(s): attorneys, firms, and roles (lead counsel, of counsel, local counsel).

Save related patent research

Not yet generated. Click Generate to run the LLM with web-search grounding (~30-60s).